Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Virtual

Dec 08, 2021 9:50 AM - Dec 09, 2021 4:30 PM

(US Eastern Standard Time)

Diagnostics and Personalized Medicine Conference

This event is now offered in a new entirely virtual format.

Session 7: Global Developments & Potential Impact to Co-Development Strategies

Session Chair(s)

Lakshman  Ramamurthy, PhD

Lakshman Ramamurthy, PhD

Head of Global Regulatory, Precision Medicine and Digital Health

GlaxoSmithKline, United States

Megan  Doyle, JD, MPH

Megan Doyle, JD, MPH

Associate Vice President, Assistant General Counsel - Diagnostics

Eli Lilly & Company, United States

This session will discuss new developments in regulation and marketing of companion diagnostics globally, and potential impact on global development strategies. Specifically, the session will share challenges and considerations for executing global co-development programs. The session will focus primarily on regions outside of the U.S. and Europe, though discussions may include global impact of the approach in these regions.

Learning Objective :
  • Understand emerging developments in companion diagnostics globally.
  • Explain the considerations to assess when planning global co-development strategies.

Speaker(s)

Katherine  Wang, LLM

Speaker

Katherine Wang, LLM

Ropes & Gray LLP, China

Chief China Life Sciences Advisor

Mandi  Jacobson, LLM

Speaker

Mandi Jacobson, LLM

Hogan Lovells, Australia

Partner

Lucy  Yin, MD

Speaker

Lucy Yin, MD

AstraZeneca, China

Head of Precision Medicine, China

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.